Approval · Notice of Compliance 12618 · 2011
AVA-RISPERIDONE: Notice of Compliance 12618
Issued September 9, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12618
- Date
- September 9, 2011
- Company
- Avanstra IncCalgary, Alberta, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New Manufacturer and Product Name
- Therapeutic class
- Antipsychotic Agent
- Canadian reference product
- RISPERDAL ORAL SOLUTION (Janssen-Ortho Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AVA-RISPERIDONE | 02364344 | Cancelled Post Market |
Medicinal ingredients
- RISPERIDONE 1 G per L